Federal inspectors found Enterprise Estates Nursing Center failed to ensure its consultant pharmacist notified physicians about the continued use of Risperidone for an unapproved diagnosis. The medication violation affected a resident with Lewy body dementia who had been taking the antipsychotic daily.
Resident 8 carried diagnoses of Lewy body dementia, anxiety disorder, recurrent major depressive disorder, and impulse disorder. The resident's quarterly assessment showed moderately impaired cognition with a score of nine on a standard mental status exam. Despite these cognitive issues, the assessment documented no behavioral problems or mood issues.
The resident required maximum staff assistance for daily activities and mobility. A physician's order from May directed staff to give Risperidone, one milligram daily at bedtime, specifically for "Lewy Body Dementia with behavioral disturbance."
But there was a problem. The resident's medical record contained no documentation of behavioral disturbances that would justify the antipsychotic prescription.
The facility's consultant pharmacist had requested clarification about the diagnosis supporting Risperidone use in May. The physician responded, indicating the medication was for "Lewy Body Dementia with behavioral disturbance." However, the resident's care records showed no such behavioral issues.
Inspectors observed the medication routine firsthand. On September 23 at 8:12 AM, a certified medication aide administered medications to Resident 8 at the dining table. She crushed all medications and mixed them into vanilla pudding. The resident took the medications without any problems.
The next day, Administrative Nurse D confirmed to inspectors that the diagnosis supporting Risperidone use was unapproved. She verified the physician had not provided written rationale for the unapproved use. More significantly, she confirmed the consultant pharmacist had not attempted to notify the physician or director of nursing about the need for additional documentation regarding the continued use of the medication.
Risperidone belongs to a class of medications called antipsychotics, used to treat major mental conditions that cause breaks from reality. Federal regulations require nursing homes to ensure residents receive only necessary medications with proper medical justification.
The resident's care plan directed staff to provide gradual dose reductions as recommended by the pharmacist. It stated the consultant pharmacist and physician were supposed to review medications monthly and make changes as needed. The plan also required staff to document the last gradual dose reduction attempt and the physician's response.
But these safeguards failed. The consulting pharmacist never escalated concerns about the unapproved diagnosis to medical staff, despite identifying the documentation gap months earlier.
The care plan instructed staff to provide one-on-one reassurance and education about the disease process, medications, and procedures. It directed staff to list previous dose reduction attempts. Yet the antipsychotic continued without proper medical backing.
Enterprise Estates operates with a census of 27 residents. Inspectors selected 12 residents for review, examining five specifically for unnecessary drug use. The facility's failure centered on this single resident receiving an antipsychotic without adequate clinical justification.
When inspectors requested the facility's policy on pharmacy reviews on September 24, administrators could not provide one. This absence of written procedures may have contributed to the breakdown in communication between the consulting pharmacist and medical staff.
The violation represents a failure of the medication review system designed to protect nursing home residents from unnecessary drugs. Federal law requires monthly reviews precisely to catch situations where medications continue without proper medical support.
Lewy body dementia affects thinking, reasoning, and independent function. While behavioral disturbances can occur with this condition, they must be documented to justify antipsychotic use. The resident's assessment specifically noted no behavioral problems, contradicting the physician's stated rationale for the prescription.
The case illustrates how communication gaps between consulting pharmacists and medical staff can leave residents receiving medications they may not need. The pharmacist identified the documentation problem in May but never escalated the issue to ensure proper medical review.
Resident 8 continues taking the daily antipsychotic, crushed into vanilla pudding each morning, while questions about its medical necessity remain unresolved.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Enterprise Estates Nursing Center from 2025-11-17 including all violations, facility responses, and corrective action plans.
Additional Resources
- View all inspection reports for Enterprise Estates Nursing Center
- Browse all KS nursing home inspections